Despite referring to the unexpected reversal of the FDA's position on MSB - the authors are believing it and using it as a basis for a near term CYP uplift.
Why -because MSB suggests it is so.
Classic nearology crap.
If MSB doesn't get its BLA what then for CYP? Not handled in the report.
Will MSB actually be able to get a BLA - what evaluation of the evidence provided by MSB is done - also not handled in the report.
Reports value -- zero in my opinion.
- Forums
- ASX - By Stock
- CYP
- CYP Price Target post MSB FDA approval.
CYP Price Target post MSB FDA approval., page-3
-
- There are more pages in this discussion • 71 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CYP (ASX) to my watchlist
|
|||||
Last
25.0¢ |
Change
-0.005(1.96%) |
Mkt cap ! $56.47M |
Open | High | Low | Value | Volume |
25.0¢ | 26.0¢ | 25.0¢ | $109.5K | 435.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 7937 | 25.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
26.5¢ | 34586 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 844 | 0.250 |
3 | 103449 | 0.245 |
3 | 253505 | 0.240 |
3 | 80000 | 0.235 |
2 | 210000 | 0.230 |
Price($) | Vol. | No. |
---|---|---|
0.265 | 34586 | 2 |
0.270 | 54283 | 3 |
0.275 | 19702 | 3 |
0.280 | 63568 | 3 |
0.295 | 14000 | 2 |
Last trade - 15.49pm 14/02/2025 (20 minute delay) ? |
Featured News
CYP (ASX) Chart |
The Watchlist
WNX
WELLNEX LIFE LIMITED
Zack Bozinvoski, Managing Director
Zack Bozinvoski
Managing Director
Previous Video
Next Video
SPONSORED BY The Market Online